A medicinal product goes through a long cycle of development. From research and development (R&D) to launching a product on the market, it can take up to ten years. Each stage of this cycle involves the teamwork of business areas and specialists whose expertise is vital to creating products that make a difference in patient lives.
Our R&D is focused on five main therapeutic areas: cardiovascular disease, diabetes, cancer, neuropsychiatric diseases, and immune-inflammatory diseases. We have long been a leader in the field of cardiology and we aim to secure a place of prominence in the area of immune-inflammatory diseases.
We have 16 clinical and pharmaceutical manufacturing centres worldwide—2 in France and 4 for generics—which produce more than 600 million boxes of products each year.
Our cross-disciplinary functions are key in a world that is increasingly regulated and progressively interconnected.